Speak with a mesothelioma consultant:

Call us at 8002788675

Your Case Manager will work with you to establish the facts of you or your loved one's case. From this point on, your personal Case Manager will be available to answer questions or concerns.

Let us put our 30 years of experience to work for you.

THE SOKOLOVE PROMISE
If we find that we can move forward with your case, we'll start working right away so you don't have to waste precious time.

MesoRC: Mesothelioma Resource Center

Attorney Advertising

Call us at 8002788675

Request Free Legal Consultation

If you or a loved one has been diagnosed with mesothelioma or another asbestos-related disease, contact us for a free, no-obligation consultation.

24hour_smallTHE SOKOLOVE PROMISE
If we find that we can move forward with your case, we'll start working right away so you don't have to waste precious time.

Free Consultation

Phase III

Phase III Randomized Study of Fentanyl Sublingual Spray for Breakthrough Cancer Pain in Patients Who are Opioid Tolerant

Phase III

Location:

The Woodlands, TX:  InSys Therapeutics, Incorporated

Trial Summary:

Primary Objective:

  1. Determine the efficacy and safety of fentanyl sublingual (SL) spray for the treatment of breakthrough cancer pain in patients on around-the-clock opioids for their persistent cancer pain.

Secondary Objectives:

  1. Evaluate the safety of fentanyl SL spray in these opioid-tolerant patients.
  2. Assess the patient’s satisfaction with treatment medication.

Contact Information:

Ramesh Acharya, MD, Protocol chair

Ph: 602-910-2617

For Additional Information, Click Here